We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pre-exposure Prophylaxis With OspA-Specific Human Monoclonal Antibodies Protects Mice Against Tick Transmission of Lyme Disease Spirochetes.
- Authors
Yang Wang; Kern, Aurélie; Boatright, Naomi K.; Schiller, Zachary A.; Sadowski, Andrew; Ejemel, Monir; Souders, Colby A.; Reimann, Keith A.; Hu, Linden; Thomas Jr, William D.; Klempner, Mark S.; Wang, Yang; Thomas, William D Jr
- Abstract
<bold>Background: </bold>Tick transmission of Borrelia spirochetes to humans results in significant morbidity from Lyme disease worldwide. Serum concentrations of antibodies against outer surface protein A (OspA) were shown to correlate with protection from infection with Borrelia burgdorferi, the primary cause of Lyme disease in the United States.<bold>Methods: </bold>Mice transgenic for human immunoglobulin genes were immunized with OspA from B. burgdorferi to generate human monoclonal antibodies (HuMabs) against OspA. HuMabs were generated and tested in in vitro borreliacidal assays and animal protection assays.<bold>Results: </bold>Nearly 100 unique OspA-specific HuMabs were generated, and 4 HuMabs (221-7, 857-2, 319-44, and 212-55) were selected as lead candidates on the basis of borreliacidal activity. HuMabs 319-44, 857-2, and 212-55 were borreliacidal against 1 or 2 Borrelia genospecies, whereas 221-7 was borreliacidal (half maximal inhibitory concentration, < 1 nM) against B. burgdorferi, Borrelia afzelii, and Borrelia garinii, the 3 main genospecies endemic in the United States, Europe, and Asia. All 4 HuMabs completely protected mice from infection at 10 mg/kg in a murine model of tick-mediated transmission of B. burgdorferi<bold>Conclusions: </bold>Our study indicates that OspA-specific HuMabs can prevent the transmission of Borrelia and that administration of these antibodies could be employed as preexposure prophylaxis for Lyme disease.
- Subjects
MONOCLONAL antibodies; IMMUNOGLOBULINS; TICKS; LYME disease; LYME disease prevention; PREVENTION of infectious disease transmission; ANIMAL experimentation; ANTIGENS; BACTERIAL vaccines; BIOLOGICAL models; BITES &; stings; IMMUNIZATION; IMMUNOLOGICAL adjuvants; LIPOPROTEINS; MEMBRANE proteins; MICE; PREVENTIVE health services; RESEARCH funding; TREATMENT effectiveness; BACTERIAL antibodies; CHEMICAL inhibitors; DISEASE complications; INFECTIOUS disease transmission
- Publication
Journal of Infectious Diseases, 2016, Vol 214, Issue 2, p205
- ISSN
0022-1899
- Publication type
journal article
- DOI
10.1093/infdis/jiw151